SCHEMBL6027093

SCHEMBL6027093

COC(=O)c1cccc(COc2cccc(O)c2C=O)c1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 8/20 0.55
LOXL2 Q9Y4K0 1/20 0.50
ERN1 O75460 2/20 0.49
HPGD P15428 2/20 0.49
LMNA P02545 2/20 0.49
CYP4F2 P78329 2/20 0.49
CYP4A11 Q02928 2/20 0.49
CCR5 P51681 1/20 0.48
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 2/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11152686 0.89 MRGPRX4 (0.57) MRGPRX4LOXL2HPGDLMNACYP4F2
SCHEMBL5756261 0.88 MAPT (0.61) LOXL2HPGDLMNARAB9ASMN1; SMN2
SCHEMBL21383460 0.86 LMNA (0.43) MRGPRX4LOXL2ERN1HPGDLMNA
SCHEMBL6027574 0.86 MRGPRX4 (0.60) MRGPRX4HPGDRAB9ASMN1; SMN2NPC1
SCHEMBL9368429 0.82 MRGPRX4 (0.55) MRGPRX4LOXL2HPGDLMNACYP4F2
SCHEMBL30078098 0.82 MRGPRX4 (0.55) MRGPRX4LOXL2HPGDLMNACYP4F2
SCHEMBL21383373 0.82 ERN1 (0.44) MRGPRX4ERN1HPGDLMNARAB9A
SCHEMBL21383047 0.79 L3MBTL1 (0.42) ERN1LMNARAB9AKDM4EALDH1A1
SCHEMBL21383365 0.79 MAPT (0.42) HPGDLMNARAB9AALDH1A1MAPT
SCHEMBL2370214 0.79 MAPT (0.57) ERN1RAB9ASMN1; SMN2NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US claimed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP claimed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO claimed
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US disclosed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP disclosed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO disclosed
EP-0614357-A1 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-09-14 EP disclosed
WO-1994007479-A2 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-04-14 WO disclosed
US-4410537-A 3-HYDROXY-2-FORMYLPHENOXYPENTANOIC ACID DERIVATIVES BURROUGHTS WELLCOME CO. (US) 1983-10-18 US disclosed
EP-0022229-B1 SUBSTITUTED PHENOL ETHERS, THEIR PREPARATION, INTERMEDIATES THEREFOR, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE PREPARATION THEREOF THE WELLCOME FOUNDATION LIMITED (GB) 1982-12-08 EP disclosed
EP-0022229-A1 Substituted phenol ethers, their preparation, intermediates therefor, pharmaceutical compositions containing them and the preparation thereof THE WELLCOME FOUNDATION LIMITED (GB) 1981-01-14 EP disclosed